These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33851314)

  • 41. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cumulative live birth rates for low-prognosis women over 5 years or 9 frozen-thawed embryo transfer cycles.
    Chen D; Shen X; Wang L; Kuang Y
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):233. PubMed ID: 35317752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria.
    Labarta E; Marin D; Remohí J; Bosch E
    Reprod Biomed Online; 2018 Oct; 37(4):434-441. PubMed ID: 30219283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
    PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome.
    Xu B; Chen Y; Geerts D; Yue J; Li Z; Zhu G; Jin L
    Fertil Steril; 2018 Jun; 109(6):1051-1059. PubMed ID: 29935642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve.
    Zhang W; Xie D; Zhang H; Huang J; Xiao X; Wang B; Tong Y; Miao Y; Wang X
    Front Endocrinol (Lausanne); 2020; 11():287. PubMed ID: 32457698
    [No Abstract]   [Full Text] [Related]  

  • 48. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study.
    Lee KS; Lin MH; Hwu YM; Yang JH; Lee RK
    J Ovarian Res; 2023 Mar; 16(1):49. PubMed ID: 36869354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between progesterone to number of mature oocytes index and live birth in GnRH antagonist protocols.
    Simon C; Branet L; Moreau J; Gatimel N; Cohade C; Lesourd F; Parinaud J; Leandri R
    Reprod Biomed Online; 2019 Jun; 38(6):901-907. PubMed ID: 30952493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study.
    Bu Z; Zhao F; Wang K; Guo Y; Su Y; Zhai J; Sun Y
    PLoS One; 2014; 9(6):e100011. PubMed ID: 24926883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients.
    Lin HT; Wu MH; Tsai LC; Chen TS; Ou HT
    Front Endocrinol (Lausanne); 2021; 12():780392. PubMed ID: 35095758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study.
    Ezoe K; Ni X; Kobayashi T; Kato K
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):740. PubMed ID: 33246461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.
    Lin MH; Wu FS; Hwu YM; Lee RK; Li RS; Li SH
    Reprod Biol Endocrinol; 2019 Jan; 17(1):7. PubMed ID: 30609935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: A retrospective cohort study.
    Chern CU; Li JY; Tsui KH; Wang PH; Wen ZH; Lin LT
    PLoS One; 2020; 15(7):e0235707. PubMed ID: 32628729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles.
    Smith ADAC; Tilling K; Nelson SM; Lawlor DA
    JAMA; 2015 Dec 22-29; 314(24):2654-2662. PubMed ID: 26717030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.